The potentially damaging variants in the LPA, PDIA2, APOBEC1, BRCA2, PCCB, AGPAT2, CREBBP, and MYL5 genes are in each case fairly evenly distributed between the four different dyslipidemia subphenotypes. The gene discussed is PDIA2; the disease is metabolic syndrome.